QuatRx Anticipates NDA Filing For Vaginal Atrophy Therapy Ophena In 2009/2010
The non-estrogen treatment for postmenopausal women is a potential blockbuster, CEO Zerbe tells “The Pink Sheet” DAILY.
The non-estrogen treatment for postmenopausal women is a potential blockbuster, CEO Zerbe tells “The Pink Sheet” DAILY.